Tricuspid Valve Regurgitation clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

    open to eligible people ages 18 years and up

    To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

    Los Angeles, California and other locations

Our lead scientists for Tricuspid Valve Regurgitation research studies include .

Last updated: